Search Results - "Lin, Gengpeng"
-
1
Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway
Published in Oncotarget (28-06-2016)“…Sirtuin6 (SIRT6), a member of the sirtuins protein family, plays multiple complex roles in cancer. Here, we report that elevated SIRT6 expression was…”
Get full text
Journal Article -
2
Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report
Published in Frontiers in oncology (01-08-2022)“…Next-generation sequencing technology has enabled the identification of fusion partners of anaplastic lymphoma kinase ( ) in non-small cell lung cancer, and…”
Get full text
Journal Article -
3
The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
Published in Frontiers in genetics (28-01-2022)“…RNA modification plays an important role in many diseases. A comprehensive study of tumor microenvironment (TME) characteristics mediated by RNA modification…”
Get full text
Journal Article -
4
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma
Published in Frontiers in genetics (11-03-2022)“…[This corrects the article DOI: 10.3389/fgene.2022.761681.]…”
Get full text
Journal Article -
5
Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma
Published in Diagnostics (Basel) (01-11-2022)“…Background: Long non-coding RNA (lncRNA) participates in the immune regulation of lung cancer. However, limited studies showed the potential roles of…”
Get full text
Journal Article -
6
DISSEMINATED NOCARDIOSIS WITH NOCARDIA BACTEREMIA
Published in Chest (01-10-2020)Get full text
Journal Article -
7
EVALUATION OF FRACTIONAL EXHALED NITRIC OXIDE IN INTERSTITIAL LUNG DISEASE
Published in Chest (01-10-2020)Get full text
Journal Article -
8
ROLE OF NONINVASIVE METHODS FOR ASSESSING STABLE NON-CYSTIC FIBROSIS BRONCHIECTASIS
Published in Chest (01-10-2020)Get full text
Journal Article -
9
SIGNIFICANCE OF NON-INVASIVE METHODS IN THE EVALUATION OF COPD
Published in Chest (01-10-2020)Get full text
Journal Article -
10
A 56-Year-Old Man With Fever, Anemia, and an Extremely High PCT Level
Published in Chest (2013)Get full text
Conference Proceeding -
11
Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation
Published in Clinical lung cancer (01-09-2021)“…•Osimertinib is widely used in patients with lung cancer with EGFR T790M after EGFR TKI treatment with high efficacy and approved in first-line treatment for…”
Get full text
Journal Article -
12
Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer
Published in Journal of thoracic oncology (01-02-2014)“…Chronic obstructive pulmonary disease (COPD) is an independent risk factor for lung cancer development, but the mechanism is not fully understood. Muscarinic…”
Get more information
Journal Article -
13
Acinar-Predominant Pattern Correlates With Poorer Prognosis in Invasive Mucinous Adenocarcinoma of the Lung
Published in American journal of clinical pathology (29-03-2018)“…Abstract Objectives Invasive mucinous adenocarcinoma (IMA) is a variant of lung adenocarcinoma with several growth patterns, such as lepidic acinar and…”
Get full text
Journal Article -
14
Emergence of NOTCH2-NTRK1 After Osimertinib in a Patient With Lung Adenocarcinoma With Neuroendocrine Differentiation
Published in Clinical lung cancer (01-03-2021)Get full text
Journal Article -
15
A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma
Published in Current oncology (Toronto) (24-10-2024)“…We present a case of a lung adenocarcinoma patient harboring a novel kinesin family member 5B (KIF5B)-NTRK1 gene fusion that responds well to entrectinib…”
Get full text
Journal Article -
16
A Phase II Study of Osimertinib Combined With Platinum Plus Pemetrexed in Patients With EGFR-Mutated Advanced Non–Small-cell Lung Cancer: The OPAL Study (NEJ032C/LOGIK1801)
Published in Clinical lung cancer (01-03-2021)“…Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, is now a standard treatment of previously untreated…”
Get full text
Journal Article -
17
Endothelial progenitor cell dysfunction in acute exacerbation of chronic obstructive pulmonary disease
Published in Molecular medicine reports (01-10-2017)“…Endothelial progenitor cells (EPCs) are decreased in cardiac dysfunction morbidity associated with acute exacerbation of chronic obstructive pulmonary disease…”
Get full text
Journal Article -
18
Low prognostic nutrition index predicts poorer quality of life in late-stage lung cancer
Published in Annals of palliative medicine (01-11-2020)“…Quality of life (QOL) is one of the most important endpoints in lung cancer care. Both nutritional and immune status reportedly correlate with QOL, so we…”
Get full text
Journal Article -
19
The role of the β2 adrenergic receptor on endothelial progenitor cells dysfunction of proliferation and migration in chronic obstructive pulmonary disease patients
Published in Expert opinion on therapeutic targets (01-06-2013)“…Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD),…”
Get more information
Journal Article -
20
CUEDC2 down-regulation is associated with tumor growth and poor prognosis in lung adenocarcinoma
Published in Oncotarget (21-08-2015)“…CUE domain-containing 2 (CUEDC2) is a multi-functional protein, which regulates cell cycle, growth factor signaling and inflammation. We found that CUEDC2 was…”
Get full text
Journal Article